Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
| Main Authors: | , , , , |
|---|---|
| Other Authors: | |
| Format: | Conference item |
| Language: | English |
| Published: |
Oxford University Press
2017
|